Evidence map›Paper›PMID 38292900›Full record

ArticleFrontiers in neuroscience2023

Advancements in high-resolution 3D microscopy analysis of endosomal morphology in postmortem Alzheimer's disease brains.

Shannon E Rose, C Andrew Williams, Dale W Hailey, Swati Mishra, Amanda Kirkland, C Dirk Keene, Gwenn A Garden, Suman Jayadev, Jessica E Young

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shannon E RoseDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA,United States.
C Andrew WilliamsDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA,United States.
Dale W HaileyInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, United States.
Swati MishraDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA,United States.
Amanda KirklandDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA,United States.
C Dirk KeeneDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA,United States.
Gwenn A GardenDepartment of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Suman JayadevInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, United States.
Jessica E YoungDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA,United States.
University of Washington · USUniversity of North Carolina at Chapel Hill · US

Funding

Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergicsU19AG066567 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Nicole M. Gatto · 2021 to 2026
$80.4M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Thomas J. Grabowski · 2020 to 2026
$29.0M
Mechanisms of Brain Dysmorphology in MN1 C-Terminal Truncation Syndrome, a Novel Intellectual Developmental Disability Disorder P50HD103524 · NICHD · UNIVERSITY OF WASHINGTON · PI Sandra E Juul · 2020 to 2026
$9.9M
Understanding the functional impact of cumulative genetic risk in Alzheimer DiseaseRF1AG063540 · NIA · UNIVERSITY OF WASHINGTON · PI GARDEN, GWENN A, JAYADEV, SUMAN · 2019 to 2020
$4.6M
Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons.R01AG062148 · NIA · UNIVERSITY OF WASHINGTON · PI YOUNG, JESSICA ELAINE · 2018 to 2022
$3.2M
NIA NIH HHS P30 AG066509NIA NIH HHS R01 AG062148NIA NIH HHS RF1 AG063540NIA NIH HHS U19 AG066567NICHD NIH HHS P50 HD103524
6 · The paper itself

Abstract

Abnormal endo-lysosomal morphology is an early cytopathological feature of Alzheimer's disease (AD) and genome-wide association studies (GWAS) have implicated genes involved in the endo-lysosomal network (ELN) as conferring increased risk for developing sporadic, late-onset AD (LOAD). Characterization of ELN pathology and the underlying pathophysiology is a promising area of translational AD research and drug development. However, rigorous study of ELN vesicles in AD and aged control brains poses a unique constellation of methodological challenges due in part to the small size of these structures and subsequent requirements for high-resolution imaging. Here we provide a detailed protocol for high-resolution 3D morphological quantification of neuronal endosomes in postmortem AD brain tissue, using immunofluorescent staining, confocal imaging with image deconvolution, and Imaris software analysis pipelines. To demonstrate these methods, we present neuronal endosome morphology data from 23 sporadic LOAD donors and one aged non-AD control donor. The techniques described here were developed across a range of AD neuropathology to best optimize these methods for future studies with large cohorts. Application of these methods in research cohorts will help advance understanding of ELN dysfunction and cytopathology in sporadic AD.

Indexed as

Alzheimer’s diseaseconfocal microscopyearly endosomeendo-lysosomal networkhigh-resolution imagingImarisneuronspostmortem brain

Identifiers

PMID38292900
PMCPMC10824887
OpenAlexW4390917554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.